And yes, another article today about the Youtube channel Bloomberg Markets and Finance, you are starting to be used to it you who follow assiduously Croblanc for so many years already! The interest for this channel keeps growing over the years and we are very happy to share it with you once again. And that's why we're telling you about it today, this brand new video should interest you.
To watch the video Novo Nordisk Sees Obesity Drug Fueling Record Profit that was posted today by the Youtube channel Bloomberg Markets and Finance, click on the video just above. You will then be able to discover it in streaming for free directly on our site!
This video is currently making the buzz on the internet and may end up in the Youtube trends. It was published a few hours ago by the videographer of the Youtube channel Bloomberg Markets and Finance who regularly publishes videos similar to the content we are talking about today.
Do you have a problem with this video? Or did you see a small error in the content you just watched? First solution to contact the author of this video is on Youtube: Try to find his email address in "About". If you don't get an answer, you can try again to contact him but on another platform. Twitter seems to be a pretty easy way to contact a Youtuber about one of his contents.
You now have all the information about the video Novo Nordisk Sees Obesity Drug Fueling Record Profit, we hope you like it and that you found it interesting. When we write an article and we see that it gets views because our community likes it, we can't wait to convince you to come back and read us more often! So do us a favor and come back regularly on Croblanc to follow other videos of Bloomberg Markets and Finance.
Friends, this is already the end of this little editorial, see you soon for a new article on Croblanc!
For your information, you can find below the description of the video Novo Nordisk Sees Obesity Drug Fueling Record Profit published by the Youtube channel Bloomberg Markets and Finance:
Novo Nordisk President and Chief Executive Officer Lars Fruergaard Jorgensen discusses soaring demand for the company's obesity drug Wegovy with Francine Lacqua on "Bloomberg Surveillance Early Edition."
Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com
Connect with us on...
Twitter: https://twitter.com/business
Facebook: https://www.facebook.com/bloombergbusiness/
Instagram: https://www.instagram.com/quicktake/?hl=en